Aston, United Kingdom

R P Beckett

This inventor holds 2 USPTO granted patents. Top assignee: British Bio-Technology Limited. Active years: 1994-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: R P Beckett. Retrieved from https://idiyas.com/inventor/r-p-beckett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1994-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: R P Beckett: Innovator in Collagenase Inhibition

Introduction

R P Beckett is a notable inventor based in Aston, GB. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit collagenase activity. With a total of 2 patents to his name, Beckett's work is crucial in addressing various diseases related to collagen degradation.

Latest Patents

Beckett's latest patents focus on P2'-modified hydroxamic acid collagenase inhibitors. These compounds, represented by a general formula, exhibit collagenase inhibition activity. They are particularly useful in managing diseases such as rheumatoid arthritis, corneal ulceration, osteoporosis, periodontitis, gingivitis, and tumor invasion. The innovative nature of these compounds highlights Beckett's commitment to advancing medical science.

Career Highlights

R P Beckett is associated with British Bio-technology Limited, where he continues to contribute to groundbreaking research. His work has implications for various medical conditions, showcasing his dedication to improving patient outcomes through innovative solutions.

Collaborations

Beckett has collaborated with notable coworkers, including M J Crimmin and A H Davidson. These partnerships have likely enhanced the scope and impact of his research endeavors.

Conclusion

R P Beckett's contributions to the field of collagenase inhibition are significant and impactful. His innovative patents and collaborations reflect his commitment to advancing medical research and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…